相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study
Dana Danino et al.
CLINICAL INFECTIOUS DISEASES (2022)
Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries
Carsten Mantel et al.
CLINICAL INFECTIOUS DISEASES (2022)
Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis
Ting Shi et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You Li et al.
LANCET (2022)
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy
Eric A. F. Simoes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Laura L. Hammitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus
Joseph A. Lewnard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
Beate Schmoele-Thoma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
Andrea G. Buchwald et al.
CLINICAL INFECTIOUS DISEASES (2021)
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
Eric A. F. Simoes et al.
CLINICAL INFECTIOUS DISEASES (2021)
Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study
David E. Tabor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study
You Li et al.
LANCET RESPIRATORY MEDICINE (2021)
Respiratory syncytial virus B sequence analysis reveals a novel early genotype
Juan C. Munoz-Escalante et al.
SCIENTIFIC REPORTS (2021)
Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in US adults, 2015-2017
Jenna E. Holmen et al.
BMC INFECTIOUS DISEASES (2021)
Implementation strategies for passive respiratory syncytial virus immunisation
Charles J. Sande
LANCET INFECTIOUS DISEASES (2021)
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study
You Li et al.
LANCET INFECTIOUS DISEASES (2021)
Preventing respiratory syncytial virus (RSV) disease in children After many decades, promising strategies for RSV immunization are on the horizon
Ruth A. Karron
SCIENCE (2021)
Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia
I-Ching Sam et al.
VACCINE (2021)
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
Ranju Baral et al.
BMJ OPEN (2021)
Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in Rural Maharashtra, India
Eric A. F. Simoes et al.
CLINICAL INFECTIOUS DISEASES (2021)
Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
Padmini Srikantiah et al.
CLINICAL INFECTIOUS DISEASES (2021)
Deaths Attributed to Respiratory Syncytial Virus in Young Children in High-Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS)
Dianna M. Blau et al.
CLINICAL INFECTIOUS DISEASES (2021)
RSV neutralization assays - Use in immune response assessment
Rama Raghunandan et al.
VACCINE (2021)
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions
Rachel S. Laufer et al.
VACCINE (2021)
Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities
Di Liu et al.
VACCINE (2021)
Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review
Alex Mezei et al.
EPIDEMICS (2021)
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
Jefferson Antonio Buendia et al.
PHARMACOECONOMICS-OPEN (2021)
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
Ting Shi et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Direct medical costs of RSV-related bronchiolitis hospitalizations in a middle-income tropical country
C. E. Rodriguez-Martinez et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2020)
Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance-opportunities and challenges
Shobha Broor et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)
A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis
Amir Kirolos et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Clinical characteristics, predictors, and performance of case definition-Interim results from the WHO global respiratory syncytial virus surveillance pilot
Siddhivinayak Hirve et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)
Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants
Gabriel Rainisch et al.
VACCINE (2020)
Pediatric Antibiotic Prescribing in China According to the 2019 World Health Organization Access, Watch, and Reserve (AWaRe) Antibiotic Categories
Chu-ning Wang et al.
JOURNAL OF PEDIATRICS (2020)
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
Xiao Li et al.
BMC MEDICINE (2020)
Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance
Mandeep Chadha et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2020)
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis
Shanshan Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Drivers and barriers of vaccine acceptance among pregnant women in Kenya
Nancy A. Otieno et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Coverage and Timeliness of Birth Dose Vaccination in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
Oumar Bassoum et al.
VACCINES (2020)
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
M. Pamela Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
Ranju Baral et al.
VACCINE (2020)
Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design
You Li et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination
Michiel van Boven et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
Ranju Baral et al.
PLOS ONE (2020)
Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health
Heather J Zar et al.
Lancet Global Health (2020)
Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis
David Hodgson et al.
BMC MEDICINE (2020)
Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi
Ranju Baral et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016
Birgitte K. Giersing et al.
VACCINE (2019)
Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations
Sonali Kochhar et al.
VACCINE (2019)
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
Katherine L. O'Brien et al.
LANCET (2019)
The burden of respiratory infections among older adults in long-term care: a systematic review
Arielle Childs et al.
BMC GERIATRICS (2019)
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis
You Li et al.
LANCET GLOBAL HEALTH (2019)
Inappropriate Antibiotic Prescribing for Acute Bronchiolitis in US Emergency Departments, 2007-2015
Jesse Papenburg et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2019)
Respiratory syncytial virus A genotype classification based on systematic intergenotypic and intragenotypic sequence analysis
Juan Carlos Munoz-Escalante et al.
SCIENTIFIC REPORTS (2019)
Laboratory-Confirmed Respiratory Infections as Predictors of Hospital Admission for Myocardial Infarction and Stroke: Time-Series Analysis of English Data for 2004-2015
Ruth Blackburn et al.
CLINICAL INFECTIOUS DISEASES (2018)
Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
Charlotte Warren-Gash et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study
Samir K. Saha et al.
LANCET (2018)
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Jeffrey C. Kwong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study
Jessica A. Fleming et al.
VACCINE (2018)
Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy
Nienke M. Scheltema et al.
VACCINE (2018)
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field
Prasad S. Kulkarni et al.
VIRAL IMMUNOLOGY (2018)
Association of seasonal viral acute respiratory infection with pneumococcal disease: a systematic review of population-based studies
You Li et al.
BMJ OPEN (2018)
Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children
Terho Heikkinen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit
Daijiro Nabeya et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations
Sonali Kochhar et al.
VACCINE (2017)
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach
Wirichada Pan-Ngum et al.
VACCINE (2017)
Safety assessment of immunization in pregnancy
Sonali Kochhar et al.
VACCINE (2017)
Potential impact of a maternal vaccine for RSV: A mathematical modelling study
Alexandra B. Hogan et al.
VACCINE (2017)
The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood
Brigitte Fauroux et al.
INFECTIOUS DISEASES AND THERAPY (2017)
Respiratory syncytial virus outbreak on an adult stem cell transplant unit
Sean G. Kelly et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2016)
Local variations in the timing of RSV epidemics
Douglas B. Noveroske et al.
BMC INFECTIOUS DISEASES (2016)
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015
Kayvon Modjarrad et al.
VACCINE (2016)
Advances in RSV vaccine research and development - A global agenda
Deborah Higgins et al.
VACCINE (2016)
Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data
Koen B. Pouwels et al.
PLOS ONE (2016)
Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina
Debora Natalia Marcone et al.
BMC INFECTIOUS DISEASES (2015)
Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings
Piero Poletti et al.
BMC MEDICINE (2015)
Preventing hospitalizations for respiratory syncytial virus infection
Joan L. Robinson et al.
PAEDIATRICS & CHILD HEALTH (2015)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya
Joyce U. Nyiro et al.
VACCINE (2015)
Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data
Daniel M. Weinberger et al.
PLOS MEDICINE (2015)
The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya
Patrick K. Munywoki et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Clinical Characteristics and Direct Medical Cost of Respiratory Syncytial Virus Infection in Children Hospitalized in Suzhou, China
Tao Zhang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
RSV Policy Statement -Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection (vol 134, pg 415, 2014)
Michael T. Brady
PEDIATRICS (2014)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine
Stephane A. Regnier
VACCINE (2013)
Virus-induced exacerbations in asthma and CORD
Daisuke Kurai et al.
FRONTIERS IN MICROBIOLOGY (2013)
Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands
M. J. Meijboom et al.
VACCINE (2012)
Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis
Jessie R. Groothuis et al.
ADVANCES IN THERAPY (2011)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years:: A population-based cohort study
Lone Graff Stensballe et al.
CLINICAL INFECTIOUS DISEASES (2008)
Respiratory syncytial virus persistence in chronic obstructive pulmonary disease
Markus B. Sikkel et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
RSV outbreak in a paediatric intensive care unit
K Thorburn et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
PA Piedra et al.
VACCINE (2003)